These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38784964)

  • 1. Genetic associations with psychosis and affective disturbance in Alzheimer's disease.
    Antonsdottir IM; Creese B; Klei L; DeMichele-Sweet MAA; Weamer EA; Garcia-Gonzalez P; Marquie M; Boada M; Alarcón-Martín E; Valero S; ; Liu Y; Hooli B; Aarsland D; Selbaek G; Bergh S; Rongve A; Saltvedt I; Skjellegrind HK; Engdahl B; Andreassen OA; Borroni B; Mecocci P; Wedatilake Y; Mayeux R; Foroud T; Ruiz A; Lopez OL; Kamboh MI; Ballard C; Devlin B; Lyketsos C; Sweet RA
    Alzheimers Dement (N Y); 2024; 10(2):e12472. PubMed ID: 38784964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits.
    Legge SE; Jones HJ; Kendall KM; Pardiñas AF; Menzies G; Bracher-Smith M; Escott-Price V; Rees E; Davis KAS; Hotopf M; Savage JE; Posthuma D; Holmans P; Kirov G; Owen MJ; O'Donovan MC; Zammit S; Walters JTR
    JAMA Psychiatry; 2019 Dec; 76(12):1256-1265. PubMed ID: 31553412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.
    DeMichele-Sweet MAA; Klei L; Creese B; Harwood JC; Weamer EA; McClain L; Sims R; Hernandez I; Moreno-Grau S; Tárraga L; Boada M; Alarcón-Martín E; Valero S; ; Liu Y; Hooli B; Aarsland D; Selbaek G; Bergh S; Rongve A; Saltvedt I; Skjellegrind HK; Engdahl B; Stordal E; Andreassen OA; Djurovic S; Athanasiu L; Seripa D; Borroni B; Albani D; Forloni G; Mecocci P; Serretti A; De Ronchi D; Politis A; Williams J; Mayeux R; Foroud T; Ruiz A; Ballard C; Holmans P; Lopez OL; Kamboh MI; Devlin B; Sweet RA
    Mol Psychiatry; 2021 Oct; 26(10):5797-5811. PubMed ID: 34112972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide copy-number variation study of psychosis in Alzheimer's disease.
    Zheng X; Demirci FY; Barmada MM; Richardson GA; Lopez OL; Sweet RA; Kamboh MI; Feingold E
    Transl Psychiatry; 2015 Jun; 5(6):e574. PubMed ID: 26035058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
    Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS;
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms.
    Matuskova V; Veverova K; Jester DJ; Matoska V; Ismail Z; Sheardova K; Horakova H; Cerman J; Laczó J; Andel R; Hort J; Vyhnalek M
    Alzheimers Res Ther; 2024 Jan; 16(1):21. PubMed ID: 38279143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis in Alzheimer's disease.
    Murray PS; Kumar S; Demichele-Sweet MA; Sweet RA
    Biol Psychiatry; 2014 Apr; 75(7):542-52. PubMed ID: 24103379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early intervention in bipolar affective disorders: Why, when and how].
    Pouchon A; Fakra E; Haesebaert F; Legrand G; Rigon M; Schmitt E; Conus P; Bougerol T; Polosan M; Dondé C
    Encephale; 2022 Feb; 48(1):60-69. PubMed ID: 34565543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affective disturbances in Alzheimer's disease.
    Bungener C; Jouvent R; Derouesné C
    J Am Geriatr Soc; 1996 Sep; 44(9):1066-71. PubMed ID: 8790232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of depression and psychosis in Alzheimer's disease.
    Wragg RE; Jeste DV
    Am J Psychiatry; 1989 May; 146(5):577-87. PubMed ID: 2653053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
    Qian W; Fischer CE; Schweizer TA; Munoz DG
    Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study.
    Sweet RA; Bennett DA; Graff-Radford NR; Mayeux R;
    Brain; 2010 Apr; 133(Pt 4):1155-62. PubMed ID: 20147454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.
    Sweet RA; Kamboh MI; Wisniewski SR; Lopez OL; Klunk WE; Kaufer DI; DeKosky ST
    J Geriatr Psychiatry Neurol; 2002; 15(1):24-30. PubMed ID: 11936240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis.
    Hollingworth P; Hamshere ML; Holmans PA; O'Donovan MC; Sims R; Powell J; Lovestone S; Myers A; DeVrieze FW; Hardy J; Goate A; Owen M; Williams J
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):841-8. PubMed ID: 17492769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that variation in the oligodendrocyte lineage transcription factor 2 (OLIG2) gene is associated with psychosis in Alzheimer's disease.
    Sims R; Hollingworth P; Moskvina V; Dowzell K; O'Donovan MC; Powell J; Lovestone S; Brayne C; Rubinsztein D; Owen MJ; Williams J; Abraham R
    Neurosci Lett; 2009 Sep; 461(1):54-9. PubMed ID: 19477230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
    Burke SL; Maramaldi P; Cadet T; Kukull W
    Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complex genetic architecture of Alzheimer's disease: novel insights and future directions.
    Andrews SJ; Renton AE; Fulton-Howard B; Podlesny-Drabiniok A; Marcora E; Goate AM
    EBioMedicine; 2023 Apr; 90():104511. PubMed ID: 36907103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes.
    Schulze TG; Ohlraun S; Czerski PM; Schumacher J; Kassem L; Deschner M; Gross M; Tullius M; Heidmann V; Kovalenko S; Jamra RA; Becker T; Leszczynska-Rodziewicz A; Hauser J; Illig T; Klopp N; Wellek S; Cichon S; Henn FA; McMahon FJ; Maier W; Propping P; Nöthen MM; Rietschel M
    Am J Psychiatry; 2005 Nov; 162(11):2101-8. PubMed ID: 16263850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Overlap Between Alzheimer's Disease and Bipolar Disorder Implicates the MARK2 and VAC14 Genes.
    Drange OK; Smeland OB; Shadrin AA; Finseth PI; Witoelar A; Frei O; ; Wang Y; Hassani S; Djurovic S; Dale AM; Andreassen OA
    Front Neurosci; 2019; 13():220. PubMed ID: 30930738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.